ES2218814T3 - Uso de queleritrina y radiacion para el tratamiento de tumores. - Google Patents

Uso de queleritrina y radiacion para el tratamiento de tumores.

Info

Publication number
ES2218814T3
ES2218814T3 ES98914302T ES98914302T ES2218814T3 ES 2218814 T3 ES2218814 T3 ES 2218814T3 ES 98914302 T ES98914302 T ES 98914302T ES 98914302 T ES98914302 T ES 98914302T ES 2218814 T3 ES2218814 T3 ES 2218814T3
Authority
ES
Spain
Prior art keywords
cheleritrine
radiation
tumor treatment
chelerythrine
irradiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98914302T
Other languages
English (en)
Inventor
Ralph R Weichselbaum
Jose Quintans
Steven J Chmura
Donald W Kufe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dana Farber Cancer Institute Inc
Arch Development Corp
Original Assignee
Dana Farber Cancer Institute Inc
Arch Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Institute Inc, Arch Development Corp filed Critical Dana Farber Cancer Institute Inc
Application granted granted Critical
Publication of ES2218814T3 publication Critical patent/ES2218814T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La combinación de dosis bajas de irradiación y queleritrina da como resultado un aumento de la apoptosis en las células tumorales. Las dosis tanto de irradiación como de queleritrina en solitario son tales que no se espera un aumento de la apoptosis o una disminución del desarrollo o proliferación del tumor.
ES98914302T 1997-03-25 1998-03-25 Uso de queleritrina y radiacion para el tratamiento de tumores. Expired - Lifetime ES2218814T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/826,814 US6025365A (en) 1997-03-25 1997-03-25 Chelerythrine and radiation combined tumor therapy

Publications (1)

Publication Number Publication Date
ES2218814T3 true ES2218814T3 (es) 2004-11-16

Family

ID=25247609

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98914302T Expired - Lifetime ES2218814T3 (es) 1997-03-25 1998-03-25 Uso de queleritrina y radiacion para el tratamiento de tumores.

Country Status (12)

Country Link
US (1) US6025365A (es)
EP (1) EP0971710B1 (es)
JP (1) JP2001521552A (es)
CN (1) CN1172668C (es)
AT (1) ATE267599T1 (es)
AU (1) AU737613B2 (es)
CA (1) CA2284992A1 (es)
DE (1) DE69824165T2 (es)
DK (1) DK0971710T3 (es)
ES (1) ES2218814T3 (es)
PT (1) PT971710E (es)
WO (1) WO1998042339A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426351B1 (en) * 2000-08-11 2002-07-30 Dana-Farber Cancer, Inc. Chelerythrine-based therapies for cancer
US20050043534A1 (en) * 2001-07-11 2005-02-24 Alicja Bielawska Modulators of ceramidase and methods of used based thereon
US20030028097A1 (en) * 2001-08-03 2003-02-06 D'amico Anthony V. Immobilizer probe system and method
US20060084697A1 (en) * 2002-08-08 2006-04-20 Hallahan Dennis E Pi3k antagonists as radiosensitizers
JP2004284961A (ja) * 2003-03-19 2004-10-14 Okinawa Pref Gov 抗腫瘍成分をサルカケミカンから抽出した製剤、食品または食品添加物
CN1292750C (zh) * 2003-06-02 2007-01-03 张平 植物来源总生物碱组合物及其药物制剂
MX2007001155A (es) * 2004-07-29 2007-08-14 Creabilis Therapeutics Spa Uso de inhibidores de k-252a y de quinasa para la prevencion o el tratamiento de patologias asociadas con hmgb1.
KR100822887B1 (ko) 2006-10-12 2008-04-17 한국생명공학연구원 치매의 치료 또는 예방을 위한 조성물
ITMI20080284A1 (it) * 2008-02-22 2009-08-23 Indena Spa Agenti antitumorali a struttura benzofenantridinica e formulazioni che li contengono
CN101904849A (zh) * 2010-08-19 2010-12-08 苏州大学 血根碱制备肿瘤放射治疗增敏药物的应用
CN102552264A (zh) * 2012-02-28 2012-07-11 苏州大学 血根碱在制备电离辐射防护剂中的应用
CN116407537A (zh) * 2023-03-03 2023-07-11 长春中医药大学 一种白屈菜红碱在制备用于治疗卵巢癌的药物中的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US433257A (en) * 1890-07-29 Salve
US209331A (en) * 1878-10-29 Improvement in medical compounds
US2344830A (en) * 1940-08-15 1944-03-21 Wisconsin Alumni Res Found Composition of matter for the chemical fixation of diseased tissue preparatory for surgical removal
US4145412A (en) * 1977-02-14 1979-03-20 Vipont Chemical Company Composition for application to oral cavity and method for preparation thereof
US4406881A (en) * 1980-05-20 1983-09-27 Vipont Laboratories Antimicrobial agent
US4376115A (en) * 1980-08-05 1983-03-08 Mccrorey Howard S Method and composition for treating teeth and method for preparing same
US4599228A (en) * 1981-01-19 1986-07-08 Vipont Laboratories, Inc. Antimicrobial agent
US5324520A (en) * 1988-12-19 1994-06-28 Vipont Pharmaceutical, Inc. Intragingival delivery systems for treatment of periodontal disease
US5137912A (en) * 1991-01-28 1992-08-11 National Science Council Of Republic Of China Chelerythrine inhibits platelet aggregation--a potential anti-aggregation drug
US5571797A (en) * 1994-05-11 1996-11-05 Arch Development Corporation Method of inducing gene expression by ionizing radiation
AU6714396A (en) * 1995-07-28 1997-02-26 Trustees Of Boston University Methods and compositions for treating cell proliferative disorders
HUP9601096A2 (hu) * 1996-04-26 1998-01-28 János Aradi Anti-HIV-aktivitással rendelkező gyógynövényalapú gyógyászati és gyógyhatású készítmény,és vegyületek

Also Published As

Publication number Publication date
DE69824165D1 (de) 2004-07-01
JP2001521552A (ja) 2001-11-06
EP0971710A1 (en) 2000-01-19
CN1255061A (zh) 2000-05-31
DK0971710T3 (da) 2004-09-27
CN1172668C (zh) 2004-10-27
EP0971710B1 (en) 2004-05-26
DE69824165T2 (de) 2005-06-09
CA2284992A1 (en) 1998-10-01
AU737613B2 (en) 2001-08-23
PT971710E (pt) 2004-09-30
WO1998042339A1 (en) 1998-10-01
ATE267599T1 (de) 2004-06-15
US6025365A (en) 2000-02-15
AU6869398A (en) 1998-10-20

Similar Documents

Publication Publication Date Title
BR0115087A (pt) Membro radioativo para uso em braquiterapia e métodos de fazer um membro radioativo e de tratar uma condição que responda a terapia por radiação
GB2370746B (en) High definition radiation treatment with an intensity modulating multi-leaf collimator
NO983429L (no) Anvendelse av et texaphyrin til fremstilling av et medikament for anvendelse med et kjemoterapeutisk middel i kreftkjemosensitivisering
ES2218814T3 (es) Uso de queleritrina y radiacion para el tratamiento de tumores.
DK1173252T3 (da) Produkter og fremgangsmåder til brachyterapi
ATE222769T1 (de) Verabreichung von gm-csf zur behandlung der gehirntumoren und verhütung deren wiederauftretens
AR023400A1 (es) Metodos para inducir la muerte de celulas cancerosas y la regresion de tumores
ES2175460T3 (es) Compuesto de lipoxinas y su utilizacion en el tratamiento de patologias con proliferacion celular.
ES2174895T3 (es) Combinaciones metalicas complejas con contenido en carbenos heterociclicos.
SG144712A1 (en) Nordihydroguaiartic derivaties for use in treatment of tumors
AR012626A1 (es) Una composicion farmaeutica que comprende un derivado o análogo de leptina como inhibidor de la proliferacion de células de tumor y el uso de dicha composicion farmaceutica para la manufactura de medicamento para el tratamiento de tumores
NO952781L (no) Potensiering av temozolomid i humane tumorceller
ATE375795T1 (de) Verwendung von et743 in kombinationstherapie mit dexamethason zur behandlung von krebs
PL341151A1 (en) Substituted products of condensation of n-benzyl-3-indenylacetamides with heterocyclic aldehydes for use in treating neoplastic diseases
DE69914357D1 (de) Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
ATE306281T1 (de) Antivirales mittel in kombination mit strahlentherapie zur verwendung in der behandlung von krebs
EA200200808A1 (ru) Модифицированные цитокины, предназначенные для применения в терапии рака
DE69940980D1 (de) Rana pipiens proteine und deren verwendung in der behandlung von tumoren
TW332827B (en) UV absorber
ES2187799T3 (es) Complejos de bis-platino con derivados de polimetileno como ligandos que tienen actividad antitumoral.
ATE285247T1 (de) Krebstherapie mit lymphotoxin
UY26431A1 (es) Quimioterapia de combinación
DK0938900T3 (da) Midler til forebyggelse/behandling af stomatitis
EP0285906A3 (en) Active agent for combating tumours
IL164356A0 (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy